Münchener Rück AG (MUV2)
XETRA Stock Exchange · Germany · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 556.60 |
|---|---|
| 52-week range | 437.40 – 572.60 |
| Return, 1 month / 3 months | +10.9% / +10.5% |
| Return, 1 year / 3 years | +6.1% / +69.5% |
| Trend | Uptrend |
| RSI (14) | 75 |
| Volatility (1 year) | 19.6% |
| Worst drawdown (1 year) | -19.0% |
| Average daily value traded | 139.85M EUR |
| Dividend yield | 4.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Münchener Rück, also known as Munich Re, is a reinsurance company based in Munich, Germany. It provides reinsurance to insurance companies around the world, covering property and casualty risks as well as life and health risks. Through its ERGO brand it also offers primary insurance and related financial services to individuals and businesses, mainly in Europe. The company serves insurers, corporate clients and private customers across international markets.
On this site Münchener Rück AG appears as a stock on the XETRA Stock Exchange (Germany), code MUV2, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Münchener Rück AG (MUV2) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 556.60 on 22 October 2026.
Its price-based Market X-Ray is 77 out of 100 (a strong price profile), ranking 35 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 6.1% and over the last three months it rose 10.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 76 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 10.3% | ||
| From 52-week high | -2.0% | ||
| Momentum | 62 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 10.5% | ||
| 6-month return | 4.4% | ||
| 12-month return, skipping the last month | -4.3% | ||
| Stability (higher is calmer) | 86 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 19.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.0% | ||
| Liquidity | 99 · Strong | Trades actively. | |
| Average daily value traded | 139.85M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 62 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.3% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +2.2% |
|---|---|
| 1 month | +10.9% |
| 3 months | +10.5% |
| 6 months | +4.4% |
| 1 year | +6.1% |
| 3 years | +69.5% |
| 5 years | +174.3% |
Signals
| 50-day / 200-day average | 518.03 / 504.50 |
|---|---|
| Golden / death cross (60 days) | Golden, 42 days ago |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8.60 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Apr 2026 | EUR 24.0000 |
| 2 May 2025 | EUR 20.0000 |
| 26 Apr 2024 | EUR 15.0000 |
| 8 May 2023 | EUR 11.6000 |
| 29 Apr 2022 | EUR 11.0000 |
| 29 Apr 2021 | EUR 9.8000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.